EUVIMEDEUVIMED entdecken
Crossref

Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming

Aparajita Ghosh, Anup Kumar Ghosh iD, Afreen Zaman, Prasanta Kumar Das iD

Molecular Pharmaceutics · 04.12.2023 · 20 (12) · 6391-6406

DOI: 10.1021/acs.molpharmaceut.3c00772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 07.11.2023. Verfasst von Aparajita Ghosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science Jadavpur, Kolkata 700032, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Metformin, Liver Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: University Grants Commission, Science and Engineering Research Board, Indian Association for the Cultivation of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is a significant hallmark of cancer that promotes chemoresistance by allowing tumor tissues to adapt to changes in the tumor microenvironment caused by anticancer therapies. Hepatocellular carcinoma (HCC), one of the most common types of primary tumors, is associated with recurrent metabolic reprogramming that maximizes cancer cell growth and proliferation. Herein, we developed metformin (MET)-loaded hyaluronic acid (HA)-derived carbon dots (HA-CD-MET) by a simple and green method with no involvement of any additives. HA-CD-MET was utilized for specifically binding the CD44 receptor overexpressed in HCC and induced glutamine metabolic rewiring to inhibit HCC cell proliferation. Exposure to HA-CD-MET resulted in ∼6.5-fold better anticancer efficacy against CD44+ Hep3B cells in comparison to CD44-, HepG2, and noncancerous HEK293 cells at a very low dose of 80 μg/mL. Moreover, treatment of three-dimensional (3D) tumor spheroid model of HCC (Hep3B) with HA-CD-MET resulted in ∼4.9-fold reduction in tumor size. This improved anticancer efficacy of HA-CD-MET was attributed to the inhibition of glutaminase-1 (GLS-1), a mitochondrial enzyme that hydrolyzes glutamine into glutamate as confirmed from immunofluorescence and immunoblotting experiments. Furthermore, treatment with HA-CD-MET resulted in downregulation of glucose transporter-1 (GLUT-1) in Hep3B cells. Consequently, cancer cells were starved from essential nutrients, glutamine, and glucose, leading to the enhancement in intracellular ROS generation. This increase in intracellular ROS accumulation activated AMP-activated protein kinase (AMPK) and inhibited AKT phosphorylation, leading to cancer cell apoptosis. Thus, this study offers the targeting of metabolic reprogramming by HA-CD-MET that opens up a promising strategy for therapeutic intervention in hepatocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularMetforminLiver NeoplasmsHumansHyaluronic AcidGlutamineCarbonReactive Oxygen SpeciesHEK293 CellsCell Line, TumorHyaluronan ReceptorsTumor Microenvironment

Stichwörter der Autor:innen

CD44carbon dotglutaminehyaluronic acidmetabolic reprogrammingmetformin

Substanzen

MetforminHyaluronic AcidGlutamineCarbonReactive Oxygen SpeciesHyaluronan Receptors

Autor:innen und Institutionen

  • School of Biological Sciences, Indian Association for the Cultivation of Science Jadavpur, Kolkata 700032, India.

ORCID-Profile: Anup Kumar Ghosh, Prasanta Kumar Das

Förderung

  • University Grants Commission
  • Science and Engineering Research Board
  • Indian Association for the Cultivation of Science

Zitieren

APA

Ghosh, A., Ghosh, A. K., Zaman, A., & Das, P. K. (2023). Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming. Molecular Pharmaceutics, 20(12), 6391-6406. https://doi.org/10.1021/acs.molpharmaceut.3c00772

Vancouver

Ghosh A, Ghosh AK, Zaman A, Das PK. Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming. Molecular Pharmaceutics. 2023;20(12):6391-6406. doi:10.1021/acs.molpharmaceut.3c00772

BibTeX
@article{Ghosh2023,
  author = {Ghosh, Aparajita and Ghosh, Anup Kumar and Zaman, Afreen and Das, Prasanta Kumar},
  title = {Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {12},
  pages = {6391--6406},
  doi = {10.1021/acs.molpharmaceut.3c00772}
}
Kostenlos starten →